Picture of Solco Biomedical Co logo

043100 Solco Biomedical Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Solco Biomedical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARSAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-18,7881,637-4,179-7,765-21,398
Depreciation
Amortisation
Non-Cash Items13,467-633-3891,5369,545
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-2,963-6,000-1,909-4141,580
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-6,739-3,980-5,411-5,463-9,044
Capital Expenditures-1,524-1,446-844-916-1,458
Purchase of Fixed Assets
Other Investing Cash Flow Items2,1765,3057,1692,9363,301
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities6523,8596,3252,0201,843
Financing Cash Flow Items-9.34
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.26-2381,8071,9775,858
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-6,106-3872,691-1,464-1,338